Genmab - 53 Year Dividend History | GMAB
Historical dividend payout and yield for Genmab (GMAB) since 1971. The current TTM dividend payout for Genmab (GMAB) as of April 22, 2024 is $0.00. The current dividend yield for Genmab as of April 22, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$18.977B |
$2.391B |
|
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
